Skip to contentI
Integra Lifesciences Holdings Corp
I
IARTIntegra Lifesciences Holdings Corp Q2 2016 · 10-Q
Revenue$249.31M$249.31M+17.2% vs Q2 2015 Net Income$12.76M$12.76M+155.2% vs Q2 2015 EPS Diluted$0.16$0.16+100.0% vs Q2 2015 Gross Profit$159,744,000+16.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR
Operating Cash Flowderived$38,079,000+36.1% Free Cash Flowderived$29,812,000+62.4% Margins · derivedGross margin64.1%−0.5 pt vs Q2 2015
Operating margin9.0%−2.5 pt vs Q2 2015
Net margin5.1%+2.8 pt vs Q2 2015
ended Jun 30, 2016 · filed Jul 28, 2016 · 28 d after period end